Literature DB >> 3179669

Cholelithiasis: a serious complication after total gastrectomy.

P Hauters1, A de Neve de Roden, A Pourbaix, F Aupaix, P Coumans, G Therasse.   

Abstract

To establish the incidence of cholelithiasis after total gastrectomy, patients operated on between 1979 and 1985 were reviewed. The study group consisted of 30 patients, all free of gallstones at the time of their gastrectomy. The median age of the patients was 56 years, the average follow-up 40 months. Cholelithiasis developed in 47 per cent of patients (14/30) and always within 2 years of total gastrectomy. The incidence of cholelithiasis was not related significantly to the sex or age of the patients. Morbidity from cholelithiasis was not negligible. Three of the fourteen patients presenting with gallstones required medical treatment in hospital and later came to cholecystectomy because of specific biliary symptoms. Cholelithiasis appears to be a significant complication after total gastrectomy. It may be related to the vagotomy which is performed at the time of gastrectomy.

Entities:  

Mesh:

Year:  1988        PMID: 3179669     DOI: 10.1002/bjs.1800750923

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  22 in total

1.  Multivariable analysis of cholecystectomy after gastrectomy: laparoscopy is a feasible initial approach even in the presence of common bile duct stones or acute cholecystitis.

Authors:  Joohyun Kim; Jeong Nam Cho; Sun Hyung Joo; Bum Soo Kim; Sang Mok Lee
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

2.  Gallstone formation after gastric cancer surgery.

Authors:  Takeo Fukagawa; Hitoshi Katai; Makoto Saka; Shinji Morita; Takeshi Sano; Mitsuru Sasako
Journal:  J Gastrointest Surg       Date:  2009-02-14       Impact factor: 3.452

3.  Analysis of gallstone disease after gastric cancer surgery.

Authors:  Tsung-Jung Liang; Shiuh-Inn Liu; Yu-Chia Chen; Po-Min Chang; Wei-Chun Huang; Hong-Tai Chang; I-Shu Chen
Journal:  Gastric Cancer       Date:  2017-02-02       Impact factor: 7.370

4.  Paradoxical response to cerulein on sphincter of Oddi in the patient with gastrectomy.

Authors:  K Odani; Y Nimura; A Yasui; Y Akita; S Shionoya
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

5.  Is Routine Prophylactic Cholecystectomy Necessary During Gastrectomy for Gastric Cancer?

Authors:  Jun Kimura; Chikara Kunisaki; Ryo Takagawa; Hirochika Makino; Michio Ueda; Mitsuyoshi Ota; Mari Oba; Takashi Kosaka; Hirotoshi Akiyama; Itaru Endo
Journal:  World J Surg       Date:  2017-04       Impact factor: 3.352

6.  Gallstone disease after extended (D2) lymph node dissection for gastric cancer.

Authors:  Tomotaka Akatsu; Masashi Yoshida; Tetsuro Kubota; Motohide Shimazu; Masakazu Ueda; Yoshihide Otani; Go Wakabayashi; Koichi Aiura; Minoru Tanabe; Toshiharu Furukawa; Yoshiro Saikawa; Shigeyuki Kawachi; Yukako Akatsu; Koichiro Kumai; Masaki Kitajima
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

7.  Conversion in laparoscopic cholecystectomy after gastric resection: a 15-year review.

Authors:  Shannon A Fraser; Harvey Sigman
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

8.  Pathogenesis of gall stones in Crohn's disease: an alternative explanation.

Authors:  R Hutchinson; P N Tyrrell; D Kumar; J A Dunn; J K Li; R N Allan
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

9.  Surgical anatomy of innervation of the gallbladder in humans and Suncus murinus with special reference to morphological understanding of gallstone formation after gastrectomy.

Authors:  Shuang-Qin Yi; Tetsuo Ohta; Akihiko Tsuchida; Hayato Terayama; Munekazu Naito; Jun Li; Heng-Xiao Wang; Nozomi Yi; Shigenori Tanaka; Masahiro Itoh
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

10.  Evaluation of gallbladder function before and after gastrectomy using a double-isotope method.

Authors:  T Hamasaki; Y Hamanaka; A Adachi; T Suzuki
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.